Renaissance Capital, an investment firm with a focus on emerging markets, sponsored the repackaging transaction and acted as a dealer for the notes. E.M.I.S. Finance B.V., a Dutch limited recourse investment vehicle, issued secured notes in the aggregate amount of approx. USD 15 million and purchased the respective number of common shares in Acronis as the […]
Archlet, an AI-based sourcing platform startup and ETH Zürich spin-off, just closed its USD 10M Series A Financing Round. The round was led by the European venture capitalist HV Capital. The existing investors, including
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to
Frontify, the provider of brand management software, has successfully raised an additional USD 50m in Series C funding, led by Revaia (formerly Gaia Capital Partners) with participation from HighSage Ventures and existing investors EQT Ventures,
Climeworks announced the launch of “Orca”, the world’s largest climate-positive carbon dioxide direct air capture (DAC) and storage plant in Hellisheidi, Iceland. The first of its kind plant will remove carbon dioxide from the
Anjarium Biosciences, a Swiss biotech company, recently closed a CHF 55.5 million (USD 61 million) Series A financing round, co-led by Gimv and Abingworth. The fundraising also saw significant participation from Omega Funds, Pfizer Ventures and surveyor
Walder Wyss has acted as advisor to Sleepiz in the completion of its CHF 4.4 million Series A financing round. The newly raised capital will support Sleepiz expansion of its portfolio to chronic respiratory disease monitoring.
Astrocast, the leading Swiss IoT- focused nanosatellite company, floated its shares on the Euronext Growth market in Oslo. Prior to the listing on Euronext Growth Oslo, Astrocast offered new shares to investors and raised CHF 40
Kantonsspital St. Gallen, a public-law institution, launched and priced its issuance of CHF 275 million in aggregate principal amount of CHF 150 million 0.30% bonds 2021-2036 and CHF 125 million 0.05% bonds 2021-2031. The bonds have been offered in full
